ACADM is linked to the etiology of medium chain acyl-CoA dehydrogenase deficit (MCADD) [65,66,67] and is primarily engaged in the mitochondrial fatty acid-oxidation pathway, which affects the body’s energy metabolism. The gene discussed is ACADM; the disease is medium chain acyl-CoA dehydrogenase deficiency.